| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |